G
GL Pharm Tech Corp
KOSDAQ:204840
GL Pharm Tech Corp
KOSDAQ:204840
Price:
1 056
KRW
-2.58%
Market Closed
Market Cap:
₩81.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
KR |
|
Albemarle Corp
NYSE:ALB
|
US |
|
X2M Connect Ltd
ASX:X2M
|
AU |
|
K
|
KMF Builders and Developers Ltd
BSE:531578
|
IN |
|
Glunz & Jensen Holding A/S
CSE:GJ
|
DK |
|
T
|
Telefonica Deutschland Holding AG
XETRA:O2D
|
DE |
|
O
|
Oriental Watch Holdings Ltd
HKEX:398
|
HK |
|
Shouhui Group Ltd
HKEX:2621
|
CN |
|
Creightons PLC
LSE:CRL
|
UK |
Multiples-Based Value
The Multiples-Based Value for GL Pharm Tech Corp (204840) under the Base Case is hidden KRW. Compared with the current market price of 1 056 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GL Pharm Tech Corp Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
GL Pharm Tech Corp Competitors
GL Pharm Tech Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
81.5B KRW | 2.4 | 265.3 | 53.1 | 152.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.9 | 7.4 | 8.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
